Ovarian cancer poses a significant threat to women due to its often asymptomatic early stages, which delay detection until it reaches an advanced and more challenging phase. The disease is particularly insidious as symptoms may not manifest visibly, leading to delayed diagnosis and treatment initiation. Diabetes has been identified as a factor that heightens the risk of developing ovarian cancer, complicating the health landscape for affected individuals. Statistics reveal a sobering reality: approximately one in 78 women will confront ovarian cancer during their lifetime, with a notable proportion being over the age of 63 years. This underscores the importance of regular health screenings and awareness campaigns to enhance early detection and improve outcomes for those at risk of this formidable cancer.
